secwatch / observer
8-K filed March 28, 2024, 7:59 PM ET ticker AMS CIK 0000744825
earnings confidence high sentiment neutral materiality 0.70

AMS Q4 2023 revenue up 13% to $5.7M; net income $0.06 vs $0.04; acquisition progress

AMERICAN SHARED HOSPITAL SERVICES

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

AMERICAN SHARED HOSPITAL SERVICES reported the fourth quarter ended December 31, 2023 results: revenue $5,698,000, EPS $0.06 per share.

Period
the fourth quarter ended December 31, 2023
Revenue
$5,698,000
EPS
$0.06 per share
Result
reported results
Exact text from the filing
SAN FRANCISCO, CA, March 27, 2024 ‒ American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy cancer treatment systems and services, today announced financial results for the fourth quarter ended December 31, 2023. Fourth Quarter 2023 Highlights ● Total revenue in the fourth quarter was $5,698,000, an increase of 13.1% from the comparable period in 2022. Total proton therapy revenue increased 36.0% period-over-period; fractions increased 30.0%. Gamma Knife revenue decreased 5.3% period-over-period; procedures decreased 15.8% due to the expiration of two customer agreements and downtime at two sites for the installation of upgraded equipment. ● Gross margin was $2,816,000, a period-over-period increase of 24.1%. The gross margin percentage was 49.4% of revenue. ● Operating income for the fourth quarter of 2023 was $407,000 compared to operating income of $590,000
View on SEC.gov

326 earnings releases filed in the last 30 days. Browse all earnings releases →

AMERICAN SHARED HOSPITAL SERVICES filing history →

Source: SEC EDGAR
accession 0001437749-24-009725
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.